早期取栓时间窗内灌注成像不匹配特征:单中心分析
这项回顾性单中心研究纳入357例早期(<6小时)接受血管内治疗的前循环大血管闭塞急性缺血性卒中患者,评估治疗前灌注参数和不匹配特征与发病时间及结局的关联。不匹配不良特征占21%至60%,与发病时间无关(P=0.490),但所有灌注参数和不匹配不良特征均与不良功能结局独立相关。
要点
- 早期取栓患者中不匹配不良特征占21%至60%,与发病时间无关(P=0.490)。
- 缺血核心体积、不匹配体积、不匹配比值均与不良功能结局独立相关。
- EXTEND-IA和DEFUSE 3不匹配不良特征还与症状性颅内出血和死亡独立相关。
核心结论
- 早期接受血管内治疗患者的治疗前灌注参数和不匹配特征与发病时间无关,但与功能结局独立相关。
- 早期时间窗内进行不匹配评估可能改善血管内治疗患者选择,且独立于发病至治疗时间。
研究设计与样本
- 回顾性单中心研究,纳入357例早期(<6小时)接受血管内治疗的前循环大血管闭塞急性缺血性卒中患者,具有基线灌注数据。
- 评估灌注参数(缺血核心体积、不匹配体积、不匹配比值)和不匹配特征(良好与不良,基于EXTEND-IA、SWIFT PRIME、DEFUSE 3和DAWN试验采用的标准)。
- 采用rs(针对参数)或χ2趋势检验(针对特征)评估与发病时间的关联,采用多变量回归分析评估与改良Rankin量表评分>2、症状性颅内出血和死亡的关联。
主要发现
- 不匹配不良特征占21%至60%,取决于所用标准,与发病时间无关(P=0.490)。
- 缺血核心体积aOR 1.49(95%CI 1.13-1.97,P=0.005)、不匹配体积aOR 0.30(95%CI 0.10-0.84,P=0.022)、不匹配比值aOR 0.67(95%CI 0.50-0.90,P=0.007)均与不良功能结局独立相关。
- EXTEND-IA不匹配不良特征aOR 2.61(95%CI 1.23-5.51,P=0.012)、SWIFT PRIME aOR 2.50(95%CI 1.30-4.57,P=0.006)、DEFUSE 3 aOR 2.28(95%CI 1.14-4.57,P=0.020)、DAWN aOR 4.19(95%CI 2.13-8.26,P<0.001)均与不良功能结局独立相关。
- EXTEND-IA和DEFUSE 3不匹配不良特征与症状性颅内出血独立相关(aOR 3.82,95%CI 1.42-10.3,P=0.008;aOR 2.83,95%CI 1.09-7.36,P=0.033)。
- EXTEND-IA和DEFUSE 3不匹配不良特征与死亡独立相关(aOR 3.26,95%CI 1.33-8.02,P=0.010;aOR 2.52,95%CI 1.10-5.82,P=0.030)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known on the role of mismatch profile in patients undergoing early endovascular treatment (EVT). We aimed to describe pretreatment perfusion parameters and mismatch profiles in anterior circulation large vessel occlusion acute ischemic stroke undergoing EVT in the early time window and assess their association with time from stroke onset and outcomes. METHODS: Retrospective single-center study, including early (<6 hours) EVT-treated large vessel occlusion acute ischemic stroke with baseline perfusion data, assessing perfusion parameters (ischemic core volume, mismatch volume and mismatch ratio) and mismatch profiles (favorable versus unfavorable, based on criteria adopted in EXTEND-IA [Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial], SWIFT PRIME [Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment], DEFUSE 3 [Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3], and DAWN [Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo] trials). We evaluated their association with time from stroke onset (rs [for parameters] or χ2 for trend [for profiles]) and association with modified Rankin Scale score >2, symptomatic intracranial hemorrhage, and mortality (multivariate regression analyses [each parameter/profile entered into a separate logistic regression model, adjusted for baseline variables associated with each outcome in the univariate analysis at the P<0.1 level]). RESULTS: Among 357 patients, unfavorable mismatch profiles ranged from 21% to 60%, depending on the criterion, and were not correlated with time from stroke onset (P=0.490). All individual perfusion parameters and unfavorable mismatch profiles were associated with poor functional outcome: ischemic core volume adjusted odds ratio (aOR), 1.49 ([95% CI, 1.13-1.97] P=0.005); penumbral volume aOR, 0.30 ([95% CI, 0.10-0.84] P=0.022); mismatch ratio aOR, 0.67 ([95% CI, 0.50-0.90] P=0.007); EXTEND-IA aOR, 2.61 ([95% CI, 1.23-5.51] P=0.012); SWIFT PRIME aOR, 2.50 ([95% CI, 1.30-4.57] P=0.006); DEFUSE 3 aOR, 2.28 ([95% CI, 1.14-4.57] P=0.020); and DAWN aOR, 4.19 ([95% CI, 2.13-8.26] P<0.001). EXTEND-IA and DEFUSE 3 unfavorable profiles were also independently associated with symptomatic intracranial hemorrhage (aOR, 3.82 [95% CI, 1.42-10.3]; P=0.008 and aOR, 2.83 [95% CI, 1.09-7.36]; P=0.033) and death (aOR, 3.26 [95% CI, 1.33-8.02]; P=0.010 and aOR, 2.52 [95% CI, 1.10-5.82]; P=0.030). CONCLUSIONS: Pretreatment perfusion parameters and mismatch profiles in early EVT-treated patients were not correlated with time from stroke onset but were independently associated with functional outcome. Mismatch assessment in the early time window may improve EVT patient selection, independently of onset-to-treatment time.
引用
- Schwarz G, Agostoni EC, Saliou G, et al. Perfusion Imaging Mismatch Profiles in the Early Thrombectomy Window: A Single-Center Analysis. Stroke. 2023. PMID: 37026456. doi:10.1161/STROKEAHA.122.041981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。